← FDA Drug Approvals (Drugs@FDA)

PRIMAXIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MERCK · Approved 1987-01-08

Drug application

FDA Application #

ANDA062756

Application type

Abbreviated New Drug Application (Generic)

Brand name

PRIMAXIN

Generic name

Cilastatin Sodium

Active ingredients

CILASTATIN SODIUM; IMIPENEM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

MERCK

First approval

1987-01-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown